Similar articles for PMID: 27807344

Year	Number of Results
2003	1
2004	4
2005	1
2006	6
2007	4
2008	9
2009	6
2010	3
2011	4
2012	1
2013	5
2014	3
2015	2
2016	1
2017	1
2024	0

1

Retraction: Effects of valsartan and amlodipine on cardiorenal protection in Japanese hypertensive patients: the Valsartan Amlodipine Randomized Trial.

Narumi H, Takano H, Shindo S, Fujita M, Mizuma H, Kuwabara Y, Komuro I. Narumi H, et al. Hypertens Res. 2017 Jan;40(1):103. doi: 10.1038/hr.2016.144. Epub 2016 Nov 3. Hypertens Res. 2017. PMID: 27807344 No abstract available.

2

Valsartan Amlodipine Randomized Trial (VART): design, methods, and preliminary results.

Nakayama K, Kuwabara Y, Daimon M, Shindo S, Fujita M, Narumi H, Mizuma H, Komuro I. Nakayama K, et al. Hypertens Res. 2008 Jan;31(1):21-8. doi: 10.1291/hypres.31.21. Hypertens Res. 2008. PMID: 18360014 Clinical Trial.

3

Effects of amlodipine and valsartan on vascular damage and ambulatory blood pressure in untreated hypertensive patients.

Ichihara A, Kaneshiro Y, Takemitsu T, Sakoda M. Ichihara A, et al. J Hum Hypertens. 2006 Oct;20(10):787-94. doi: 10.1038/sj.jhh.1002067. Epub 2006 Jun 29. J Hum Hypertens. 2006. PMID: 16810279 Clinical Trial.

4

Amlodipine seems to be superior to valsartan in decreasing microalbuminuria in newly diagnosed hypertensive patients: a novel effect to be explained with hyperfiltration?

Ay SA, Cakar M, Karaman M, Balta S, Demirkol S, Unlu M, Kurt O, Altun B, Akhan M, Arslan E, Koc B, Bulucu F. Ay SA, et al. Ren Fail. 2013;35(3):357-60. doi: 10.3109/0886022X.2012.755354. Epub 2013 Jan 9. Ren Fail. 2013. PMID: 23297711 Clinical Trial.

5

Progressive effects of valsartan compared with amlodipine in prevention of diabetes according to categories of diabetogenic risk in hypertensive patients: the VALUE trial.

Kjeldsen SE, McInnes GT, Mancia G, Hua TA, Julius S, Weber MA, Coca A, Girerd X, Jamerson K, Larochelle P, Macdonald T, Schmieder RE, Anthony Schork M, Viskoper R, Widimsky J, Zanchetti A. Kjeldsen SE, et al. Blood Press. 2008;17(3):170-7. doi: 10.1080/08037050802169644. Blood Press. 2008. PMID: 18608200 Clinical Trial.

6

Beneficial effects of combination of valsartan and amlodipine on salt-induced brain injury in hypertensive rats.

Dong YF, Kataoka K, Tokutomi Y, Nako H, Nakamura T, Toyama K, Sueta D, Koibuchi N, Yamamoto E, Ogawa H, Kim-Mitsuyama S. Dong YF, et al. J Pharmacol Exp Ther. 2011 Nov;339(2):358-66. doi: 10.1124/jpet.111.182576. Epub 2011 Aug 1. J Pharmacol Exp Ther. 2011. PMID: 21807884

7

Comparing antihypertensive effect and plasma ciclosporin concentration between amlodipine and valsartan regimens in hypertensive renal transplant patients receiving ciclosporin therapy.

Cai J, Huang Z, Yang G, Cheng K, Ye Q, Ming Y, Zuo X, Zhou P, Yuan H. Cai J, et al. Am J Cardiovasc Drugs. 2011 Dec 1;11(6):401-9. doi: 10.2165/11593800-000000000-00000. Am J Cardiovasc Drugs. 2011. PMID: 22149319 Clinical Trial.

8

Effects of valsartan compared to amlodipine on preventing type 2 diabetes in high-risk hypertensive patients: the VALUE trial.

Kjeldsen SE, Julius S, Mancia G, McInnes GT, Hua T, Weber MA, Coca A, Ekman S, Girerd X, Jamerson K, Larochelle P, MacDonald TM, Schmieder RE, Schork MA, Stolt P, Viskoper R, Widimský J, Zanchetti A; VALUE Trial Investigators. Kjeldsen SE, et al. J Hypertens. 2006 Jul;24(7):1405-12. doi: 10.1097/01.hjh.0000234122.55895.5b. J Hypertens. 2006. PMID: 16794491 Clinical Trial.

9

Outcomes in subgroups of hypertensive patients treated with regimens based on valsartan and amlodipine: An analysis of findings from the VALUE trial.

Zanchetti A, Julius S, Kjeldsen S, McInnes GT, Hua T, Weber M, Laragh JH, Plat F, Battegay E, Calvo-Vargas C, Cieśliński A, Degaute JP, Holwerda NJ, Kobalava J, Pedersen OL, Rudyatmoko FP, Siamopoulos KC, Störset O. Zanchetti A, et al. J Hypertens. 2006 Nov;24(11):2163-8. doi: 10.1097/01.hjh.0000249692.96488.46. J Hypertens. 2006. PMID: 17053536 Clinical Trial.

10

Comparative evaluation of effect of valsartan/amlodipine and atenolol/amlodipine combinations on atrial fibrillation recurrence in hypertensive patients with type 2 diabetes mellitus.

Fogari R, Zoppi A, Mugellini A, Corradi L, Lazzari P, Preti P, Derosa G. Fogari R, et al. J Cardiovasc Pharmacol. 2008 Mar;51(3):217-22. doi: 10.1097/FJC.0b013e318160b42a. J Cardiovasc Pharmacol. 2008. PMID: 18356684 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

47 results

Results by year